ANAPTYSBIO, INC (ANAB) › Capital ExpendituresANAPTYSBIO, INC (ANAB) — Capital ExpendituresAnnual figures by fiscal year, from SEC filings.2015: $238.0K2016: $50.0K2017: $290.0K2018: $1.06M2019: $805.0K2020: $569.0K2021: $1.37M2022: $358.0K2023: $807.0K2024: $358.0K2025: $87.0K$87.0K2015Capital Expenditures (USD)2025Fiscal YearCapital ExpendituresChange YoY2025$87.0K-75.7%2024$358.0K-55.6%2023$807.0K+125.4%2022$358.0K-73.8%2021$1.37M+140.1%2020$569.0K-29.3%2019$805.0K-24.3%2018$1.06M+266.6%2017$290.0K+480.0%2016$50.0K-79.0%2015$238.0K—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowShares OutstandingDividends Per Share